Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001005477-04-002709
Filing Date
2004-07-19
Accepted
2004-07-19 18:25:55
Documents
1
Period of Report
2004-07-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 edgar123.html 4  
1 FORM 4 edgar123.xml 4 9623
  Complete submission text file 0001005477-04-002709.txt   11332
Mailing Address 350 CORPORATE BLVD ROBBINSVILLE NJ 08691
Business Address 350 CORPORATE BLVD ROBBINSVILLE NJ 08691 6092089688
NEXMED INC (Issuer) CIK: 0001017491 (see all company filings)

EIN.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address NEXMED 350 CORPORATE BLVD ROBBINSVILLE NJ 08691 6092089688
EMIL ARTHUR D (Reporting) CIK: 0001245157 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-22245 | Film No.: 04920741